Publications by authors named "Susan M Blaney"

140Publications

Editorial: Recent advances in pediatric oncology.

Authors:
Susan M Blaney

Curr Opin Pediatr 2019 02;31(1):1-2

Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas, USA.

View Article and Find Full Text PDF
February 2019

Recent advances in pediatric oncology.

Authors:
Susan M Blaney

Curr Opin Pediatr 2018 02;30(1):1-2

Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas, USA.

View Article and Find Full Text PDF
February 2018

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2018 03 1;65(3). Epub 2017 Nov 1.

Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF
March 2018

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

J Clin Oncol 2017 Oct 8;35(28):3215-3221. Epub 2017 Aug 8.

Yael P. Mossé, Megan S. Lim, Delphine Rolland, Elizabeth Fox, and Peter Adamson, University of Pennsylvania, Philadelphia, PA; Stephan D. Voss, Harvard Medical School, Boston, MA; Charles G. Minard and Susan M. Blaney, Baylor College of Medicine, Houston, TX; Keith Wilner, Pfizer Oncology, La Jolla, CA; and Brenda J. Weigel, University of Minnesota Cancer Center, Minneapolis, MN.

View Article and Find Full Text PDF
October 2017

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

J Clin Oncol 2016 09 11;34(25):3031-8. Epub 2016 Jul 11.

Joanne P. Lagmay, Shands Hospital for Children, University of Florida, Gainesville, FL; Mark D. Krailo and Ha Dang, University of Southern California, Los Angeles; and Children's Oncology Group, Monrovia; Theodore Zwerdling, Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital, Long Beach, CA; AeRang Kim, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Orren Beaty III, Zeiss Children's Cancer Center, Mission Hospitals, Asheville, NC; Brigitte C. Widemann, National Institutes of Health Clinical Center, Bethesda, MD; Lisa Bomgaars and Susan M. Blaney, Baylor College of Medicine/Texas Children's Cancer Center, Houston; Anne-Marie Langevin, University of Texas Health Science Center at San Antonio, San Antonio, TX; Holcombe E. Grier and Katherine A. Janeway, Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, MA; Brenda Weigel, University of Minnesota, Minneapolis, MN; and Richard Gorlick, The Albert Einstein College of Medicine of Yeshiva University, The Children's Hospital at Montefiore, New York, NY.

View Article and Find Full Text PDF
September 2016

The 2016 ASPHO Distinguished Career Award Goes to David G. Poplack, MD.

Pediatr Blood Cancer 2016 Jun;63 Suppl 1:S5-6

Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC.

View Article and Find Full Text PDF
June 2016